Share this article
Share this article
TOKYO, Feb. 23, 2021 /PRNewswire/ Terumo Corporation (TSE: 4543), a global leader in medical technology, has signed a definitive agreement to acquire all assets of Health Outcomes Sciences, Inc. (HOS). HOS specializes in predictive analytics and clinical decision support that enable healthcare organizations to deliver personalized, predictive insights at the point of care, resulting in significant and measurable improvements in clinical, patient and financial outcomes. The acquisition of Health Outcomes Sciences and the ePRISM® platform expands Terumo s presence in the digital healthcare arena and represents a compelling growth opportunity for our company. It further allows Terumo to deliver innovative digital solutions, providing healthcare systems with critical data needed to lower the cost of healthcare delivery while substantially improving patient outcomes, said Toshi Osada, President of Terumo Corporation s Cardiac and Vascular Com